Assessing Guideline-Directed Medication Therapy for Heart Failure in End-Stage Renal Disease

Although there were no differences in the primary outcomes, the shorter LOS in the GDMT group may be clinically significant. The fact that most patients with ESRD and HFrEF were not receiving GDMT is a finding that requires further evaluation.